Interpreting overdiagnosis estimates in population-based mammography screening
about
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methodsOverdiagnosis and overtreatment of prostate cancerThe contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.Women's views on overdiagnosis in breast cancer screening: a qualitative study.Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom.Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United KingdomBenefit-to-harm ratio of the Danish breast cancer screening programme.Cancer screening: the journey from epidemiology to policy.Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task ForceOverdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data.Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use.Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland.Overdiagnosis: epidemiologic concepts and estimation.Variation in Breast Cancer-Risk Factor Associations by Method of Detection: Results From a Series of Case-Control StudiesEvaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulationCost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review.High sensitivity non-invasive detection of calcifications deep inside biological tissue using Transmission Raman Spectroscopy.Overdiagnosis in screening mammography in Denmark: population based cohort studyBenefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.Which strategies reduce breast cancer mortality most? Collaborative modeling of optimal screening, treatment, and obesity preventionIncidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.Overdiagnosis among women attending a population-based mammography screening program.Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening.Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population StudiesStage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening programOverdiagnosis in lung cancer screening: why modelling is essentialImmediate and delayed effects of mammographic screening on breast cancer mortality and incidence in birth cohorts.Recognizing the Limitations of Cancer Overdiagnosis Studies: A First Step Towards Overcoming Them.Mammographic screening detects low-risk tumor biology breast cancers.Overdiagnosis of breast cancer in population screening: does it make breast screening worthless?Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review.Position paper: breast cancer screening, diagnosis, and treatment in Denmark.Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers?Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects.The UK breast screening program - what you need to know.The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer.The Japanese Guidelines for Breast Cancer Screening.The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
P2860
Q26824867-9C4E4A7B-7E40-4894-9A88-0468B9B6D9C7Q26859596-56735318-9214-40E2-90E2-65F405C422AAQ27347267-7958026C-4A2E-4A84-B430-79D1A3467829Q27347760-437576C0-402C-4E42-9E91-C7A5790DD880Q30532790-219BAFC0-3B55-4CF4-AA6C-8793322AFA2BQ33613703-5A82E07C-AF6D-41B0-B27E-2C2DED42CCF8Q33739409-A939DA09-8DED-49DB-9CD2-D3171C58CD0BQ33845856-B77478F6-BDBC-470A-8466-0682DAB867AFQ33897050-F54DFC66-9345-4439-A799-BD7A517B20DFQ33978331-0B54E14F-A5D7-4316-A515-9A1CA2698F22Q34082491-9F90B540-2427-4353-8581-2B9DA0E74F91Q34145175-87DB3181-7ABD-4B66-BBCF-E6C11B6CE176Q34283688-3A830A30-CC27-456D-80C4-E4F8ACAA92F9Q35438645-3EEF8301-A9B7-42BA-ADF6-AC3FB06755E6Q35713073-103E1A5A-EC37-4871-84DF-BD2DE0305E99Q35803986-55E07C63-E6D0-44AB-B819-3117A8ACD060Q36276324-6EFE3382-013B-4044-B5D7-8CC3511EB0EDQ36411029-6FA2F656-C101-4674-B478-664D373C6825Q36638777-F72EAD44-AAB2-473B-8AFF-0D7029F2A69FQ36770273-A6E73CEA-7861-47A1-A88E-370FD83B6A0FQ36887123-DD8E5F25-A7C2-477C-AA1B-3B15BC43E937Q36980173-6D1AD6A6-9AAC-4151-82AE-36BC613D92A6Q37001469-ECB52C6E-212C-44CF-A2AC-231074FE0E4FQ37001743-2F1E4F1D-B3A0-4715-940C-9F8EC4A99771Q37070417-30C92F76-D99C-4320-B4A9-5E00ADBD08F4Q37096178-4803C318-41CF-4832-8284-7F40F6429637Q37116679-F06FCE3E-459D-46C2-A8A6-5F88CC5004A2Q37162900-B615C7C1-74B6-4973-8DF1-B155F05DBD63Q37279323-0288E920-8557-4947-A82B-B011F73FEB7DQ37353833-94A7499A-4E67-4A17-841C-7D1D68A3FA8DQ37583102-8FA23877-2A13-4EB5-A7E7-2EA5C439F949Q37720423-D8A8E7D9-8241-4BC7-8688-BED7D8B9D6ABQ38042897-5F143626-7651-485F-8E86-A2F68B4BB7C4Q38185110-F2D5BD5E-3573-4998-A86B-DFA1954CDBB1Q38254913-424DFDC9-5C50-45ED-9A09-4BBB1F753D63Q38415175-CDB84074-870B-4660-922C-2323A468A7ECQ38665126-030E2295-48ED-47E0-8FDC-98AC50A3D5ECQ38805542-D5B6E6B5-23BC-4CE1-8C41-C3341F96BDD4Q38840507-14F131FD-C4F7-4277-B1EE-DDFFC02EEDCAQ38937235-64556A23-0E7C-4A99-9485-E9032C80D5BB
P2860
Interpreting overdiagnosis estimates in population-based mammography screening
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Interpreting overdiagnosis estimates in population-based mammography screening
@ast
Interpreting overdiagnosis estimates in population-based mammography screening
@en
Interpreting overdiagnosis estimates in population-based mammography screening
@nl
type
label
Interpreting overdiagnosis estimates in population-based mammography screening
@ast
Interpreting overdiagnosis estimates in population-based mammography screening
@en
Interpreting overdiagnosis estimates in population-based mammography screening
@nl
prefLabel
Interpreting overdiagnosis estimates in population-based mammography screening
@ast
Interpreting overdiagnosis estimates in population-based mammography screening
@en
Interpreting overdiagnosis estimates in population-based mammography screening
@nl
P2093
P2860
P921
P356
P1476
Interpreting overdiagnosis estimates in population-based mammography screening
@en
P2093
Eveline A M Heijnsdijk
Gerrit Draisma
Harry J de Koning
Jacques Fracheboud
Nicolien T van Ravesteyn
Rianne de Gelder
P2860
P304
P356
10.1093/EPIREV/MXR009
P5008
P577
2011-06-27T00:00:00Z